Keep Updated February 2015

Treatment for ADPKD approved in Canada

JINARC® (tolvaptan) has been approved in Canada as a treatment for autosomal dominant polycystic kidney disease (ADPKD). JINARC® was discovered in Japan by Otsuka Pharmaceutical and was first approved there for ADPKD in 2014. The Health Canada approval of JINARC® […]

PKD Foundation |